News

SEC Filings

Document Details

Filing Date
May 20, 2022
Document Date
December 31, 2021
Form Description
Amendment to a previously filed 10-K
Filing Group
Annual Filings
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com